TRADING UPDATES: Theracryf's fund raise; Potter & Moore sales struggle
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 0.19p on 21-08-2026 at 18:35:09 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.20p |
| Sell | 0.18p |
| Last Trade: | Sell 50,000.00 at 0.1865p |
| Day's Volume: | 4,550,590 |
| Last Close: | 0.19p |
| Open: | 0.19p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.19p - 0.19p |
| 52wk Range: | 0.18p - 0.265p |
| Market Capitalisation: | £4.08m |
| VWAP: | 0.183292p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 50,000 | 0.1865p | Ordinary |
12:55:13 - 21-Aug-26 |
| Sell* | 1,072,386 | 0.1865p | Ordinary |
12:55:05 - 21-Aug-26 |
| Sell* | 150,000 | 0.18p | Ordinary |
12:41:58 - 21-Aug-26 |
| Sell* | 182,500 | 0.18p | Ordinary |
12:36:48 - 21-Aug-26 |
| Buy* | 388 | 0.20p | SI Trade |
11:57:34 - 21-Aug-26 |
| Sell* | 1,200,000 | 0.175p | Ordinary |
11:49:47 - 21-Aug-26 |
| Sell* | 1 | 0.16p | Negotiated Trade |
11:47:51 - 21-Aug-26 |
| Sell* | 1,594,154 | 0.188p | Ordinary |
08:48:45 - 21-Aug-26 |
| Buy* | 550 | 0.20p | Ordinary |
08:21:41 - 21-Aug-26 |
| Buy* | 611 | 0.20p | SI Trade |
08:21:41 - 21-Aug-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 20th Aug 2026 4:13 pm | RNS | Proposed Placing & Subscription to raise £1.05m |
| 24th Jun 2026 4:34 pm | RNS | Holding(s) in Company |
| 26th May 2026 2:40 pm | RNS | Holding(s) in Company |
| 15th May 2026 12:43 pm | RNS | Holding(s) in Company |
| 15th May 2026 7:00 am | RNS | Holding(s) in Company |
| 14th May 2026 7:00 am | RNS | Positive Ox-1 tox data in addiction programme |
| 21st Apr 2026 7:00 am | RNS-R | Investor Webinar |
| 20th Apr 2026 7:00 am | RNS | Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am | RNS | New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am | RNS | Non-Binding Proposal to Acquire TheraCryf’s Assets |